We previously observed decreased levels of VEGF-A in cerebrospinal fluid (CSF) cells from a small group of MS patients compared to controls [22].The objective of this study was to determine VEGF-A expression profiles in CSF and peripheral blood in a large cohort of well characterized MS patients and relate this to different disease measures. Here, VEGFA is linked to myeloid sarcoma.